The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease

201229 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Hypertension Research

Volume 36, Issue 3, pp. 262-269

Field-Weighted Citation Impact: 2.84